The Opus gene therapy merger represented a massive strategic pivot, executed without a shareholder vote. In the Restore Value Slate’s view, the Board structured a complex two-step merger which ...

Vurhonga Rikhotso has been appointed the new chief financial officer (CFO), effective 1 February. She takes over from CFO ...